In addition, cagrilintide is now being developed in combination with the GLP-1 agonist semaglutide as CagriSema to achieve sustained weight loss in persons with overweight and obesity
GLP-1 Microdosing Age-Specific Protocols One of our most significant discoveries has been that the aesthetic needs of a 25-year-old beginning GLP-1 therapy are vastly different from those of a 55-year-old whos been on treatment for months
Your tirzepatide can lose 5-10% of its potency while still looking perfectly clear, colorless, and particle-free
Bioengineering the metabolic network of CAR T cells with GLP-1 and urolithin A increases persistence and long-term anti-tumor activity
Registered dietitian Ayla Barmmer told The New York Post that 15% of her GLP-1 patients have encountered fertility challenges, with 40% of that group experiencing irregular menstrual cycles, delayed ovulation, or declining sperm quality, outcomes likely tied to nutrient deficiencies resulting from rapid weight loss
However, given the novelty of this therapeutic approach, the available evidence may be influenced by publication bias and early optimism, and long-term mechanistic and clinical outcome data remain limited